FDA warns Novo Nordisk over unreported potential Ozempic side effects

2026-03-10 - 17:52

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.